Clinical and microbiological profiles in post-chemotherapy neutropenic fever in hematological malignancy: exploration of clinical phenotype patterns by two-step cluster analysis.

Autor: Chan CW; School of Nursing, The Hong Kong Polytechnic University, Hong Kong, Hong Kong, Special Administrative Region of China. cwanchan@netvigator.com., Molassiotis A; School of Nursing, The Hong Kong Polytechnic University, Hong Kong, Hong Kong, Special Administrative Region of China., Lee HKK; Department of Medicine & Geriatrics, Princess Margaret Hospital, Hong Kong, Hong Kong, Special Administrative Region of China.

Publikováno v: BMC infectious diseases [BMC Infect Dis] 2023 Apr 13; Vol. 23 (1), pp. 226. Date of Electronic Publication: 2023 Apr 13.

Liver complications of haemoglobin H disease in adults.

Autor: Chan LKL; Division of Haematology, Department of Medicine and Geriatrics, Princess Margaret Hospital, Hong Kong, China., Mak VWM; Division of Haematology, Department of Medicine and Geriatrics, Princess Margaret Hospital, Hong Kong, China., Chan SCH; Department of Radiology, Princess Margaret Hospital, Hong Kong, China., Yu ELM; Clinical Research Centre, Princess Margaret Hospital, Hong Kong, China., Chan NCN; Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China., Leung KFS; Division of Haematology, Department of Pathology, Princess Margaret Hospital, Hong Kong, China., Ng CKM; Division of Gastroenterology and Hepatology, Department of Medicine and Geriatrics, Princess Margaret Hospital, Hong Kong, China., Ng MHL; Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China., Chan JCW; Division of Haematology, Department of Medicine and Geriatrics, Princess Margaret Hospital, Hong Kong, China., Lee HKK; Division of Haematology, Department of Medicine and Geriatrics, Princess Margaret Hospital, Hong Kong, China.

Publikováno v: British journal of haematology [Br J Haematol] 2021 Jan; Vol. 192 (1), pp. 171-178. Date of Electronic Publication: 2020 Oct 23.

Clofarabine, cytarabine, and mitoxantrone in refractory/relapsed acute myeloid leukemia: High response rates and effective bridge to allogeneic hematopoietic stem cell transplantation.

Autor: Gill H; Department of Medicine, The University of Hong Kong, Hong Kong SAR, China., Yim R; Department of Medicine, The University of Hong Kong, Hong Kong SAR, China., Pang HH; School of Public Health, The University of Hong Kong, Hong Kong SAR, China., Lee P; Department of Medicine, The University of Hong Kong, Hong Kong SAR, China., Chan TSY; Department of Medicine, The University of Hong Kong, Hong Kong SAR, China., Hwang YY; Department of Medicine, The University of Hong Kong, Hong Kong SAR, China., Leung GMK; Department of Medicine, The University of Hong Kong, Hong Kong SAR, China., Ip HW; Department of Pathology, Queen Mary Hospital, Hong Kong SAR, China., Leung RYY; Department of Pathology, Queen Mary Hospital, Hong Kong SAR, China., Yip SF; Department of Medicine, Tuen Mun Hospital, Hong Kong SAR, China., Kho B; Department of Medicine, Pamela Youde Nethersole Eastern Hospital, Hong Kong SAR, China., Lee HKK; Department of Medicine, Princess Margaret Hospital, Hong Kong SAR, China., Mak V; Department of Medicine, Princess Margaret Hospital, Hong Kong SAR, China., Chan CC; Department of Medicine, Queen Elizabeth Hospital, Hong Kong SAR, China., Lau JSM; Department of Medicine, Queen Elizabeth Hospital, Hong Kong SAR, China., Lau CK; Department of Medicine, Tseung Kwan O Hospital, Hong Kong SAR, China., Lin SY; Department of Medicine, United Christian Hospital, Hong Kong SAR, China., Wong RSM; Department of Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong SAR, China., Li W; Department of Clinical Oncology, Prince of Wales Hospital, Hong Kong SAR, China., Ma ESK; Department of Pathology, Hong Kong Sanatorium and Hospital, Hong Kong SAR, China., Li J; Department of Infectious Diseases and Public Health, The City University of Hong Kong, Hong Kong SAR, China.; School of Biological Sciences, The University of Hong Kong, Hong Kong SAR, China., Panagiotou G; School of Biological Sciences, The University of Hong Kong, Hong Kong SAR, China.; Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.; Department of Systems Biology and Bioinformatics, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knöll Institute (HKI), Jena, Germany., Sim JPY; Department of Medicine, The University of Hong Kong, Hong Kong SAR, China., Lie AKW; Department of Medicine, The University of Hong Kong, Hong Kong SAR, China., Kwong YL; Department of Medicine, The University of Hong Kong, Hong Kong SAR, China.

Publikováno v: Cancer medicine [Cancer Med] 2020 May; Vol. 9 (10), pp. 3371-3382. Date of Electronic Publication: 2020 Mar 18.

Oral arsenic trioxide incorporation into frontline treatment with all-trans retinoic acid and chemotherapy in newly diagnosed acute promyelocytic leukemia: A 5-year prospective study.

Autor: Gill H; Department of Medicine, University of Hong Kong, Hong Kong, China., Kumana CR; Department of Medicine, University of Hong Kong, Hong Kong, China., Yim R; Department of Medicine, University of Hong Kong, Hong Kong, China., Hwang YY; Department of Medicine, University of Hong Kong, Hong Kong, China., Chan TSY; Department of Medicine, University of Hong Kong, Hong Kong, China., Yip SF; Department of Medicine, Tuen Mun Hospital, Hong Kong, China., Lee HKK; Department of Medicine, Princess Margaret Hospital, Hong Kong, China., Mak V; Department of Medicine, Princess Margaret Hospital, Hong Kong, China., Lau JSM; Department of Medicine, Queen Elizabeth Hospital, Hong Kong, China., Chan CC; Department of Medicine, Queen Elizabeth Hospital, Hong Kong, China., Kho B; Department of Medicine, Pamela Youde Nethersole Eastern Hospital, Hong Kong, China., Wong RSM; Department of Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong, China., Li W; Department of Clinical Oncology, Prince of Wales Hospital, Hong Kong, China., Lin SY; Department of Medicine, United Christian Hospital, Hong Kong, China., Lau CK; Department of Medicine, Tseung Kwan O Hospital, Hong Kong, China., Ip HW; Department of Pathology, Queen Mary Hospital, Hong Kong, China., Leung RYY; Department of Pathology, Queen Mary Hospital, Hong Kong, China., Lam CCK; Department of Pathology, Queen Mary Hospital, Hong Kong, China., Kwong YL; Department of Medicine, University of Hong Kong, Hong Kong, China.

Publikováno v: Cancer [Cancer] 2019 Sep 01; Vol. 125 (17), pp. 3001-3012. Date of Electronic Publication: 2019 May 15.

Long-term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide-based reinduction and maintenance regimens: A 15-year prospective study.

Autor: Gill H; Department of Medicine, Queen Mary Hospital, Hong Kong, China., Yim R; Department of Medicine, Queen Mary Hospital, Hong Kong, China., Lee HKK; Department of Medicine, Princess Margaret Hospital, Hong Kong, China., Mak V; Department of Medicine, Princess Margaret Hospital, Hong Kong, China., Lin SY; Department of Medicine, United Christian Hospital, Hong Kong, China., Kho B; Department of Medicine, Pamela Youde Eastern Hospital, Hong Kong, China., Yip SF; Department of Medicine, Tuen Mun Hospital, Hong Kong, China., Lau JSM; Department of Medicine, Queen Elizabeth Hospital, Hong Kong, China., Li W; Department of Clinical Oncology, Prince of Wales Hospital, Hong Kong, China., Ip HW; Department of Pathology, Queen Mary Hospital, Hong Kong, China., Hwang YY; Department of Medicine, Queen Mary Hospital, Hong Kong, China., Chan TSY; Department of Medicine, Queen Mary Hospital, Hong Kong, China., Tse E; Department of Medicine, Queen Mary Hospital, Hong Kong, China., Au WY; Blood-Med Clinic, Hong Kong, China., Kumana CR; Department of Medicine, Queen Mary Hospital, Hong Kong, China., Kwong YL; Department of Medicine, Queen Mary Hospital, Hong Kong, China.

Publikováno v: Cancer [Cancer] 2018 Jun 01; Vol. 124 (11), pp. 2316-2326. Date of Electronic Publication: 2018 Mar 26.